Matrixx Decision Raises More Disclosure Questions – Law Professor
This article was originally published in The Tan Sheet
Executive Summary
The Supreme Court's decision in the lawsuit alleging Matrixx Initiatives fraudulently withheld adverse event reports from investors provides little guidance for pharmaceutical and dietary supplement firms on disclosing adverse events, an expert says.